PLSE PULSE BIOSCIENCES, INC.

8-K Current Report

Filed: March 17, 2026

Health Care

Surgical & Medical Instruments & Apparatus

PULSE BIOSCIENCES, INC. (PLSE) 8-K current report filed with SEC EDGAR on March 17, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 8.01: Other Events

AI Filing Analysis
8-K

Item 8.01 · Other Events

• Strategic pivot: PLSE shifting focus to nsPFA electrophysiology catheters for AFib treatment, triggered by "unprecedented" first-in-human feasibility study data released Feb 5, 2026
• Workforce restructuring underway — sales & marketing headcount being reduced as company reallocates resources toward cardiac device R&D

+2 more insights

Other PULSE BIOSCIENCES, INC. 8-K Filings

Get deeper insights on PULSE BIOSCIENCES, INC.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.